Kenneth M Grundfast, MD - Medicare Otolaryngology in Boston, MA

Kenneth M Grundfast, MD is a medicare enrolled "Otolaryngology" physician in Boston, Massachusetts. He went to State University Of Ny Upstate Medical University and graduated in 1969 and has 55 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Bumc Otolaryngologic Foundation Inc, Massachusetts Eye And Ear Associates, Inc, New England Ear Nose And Throat Llc, George Washington University Medical Faculty Associates and his current practice location is 820 Harrison Ave, Suite 4005, Boston, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (617) 638-7934.

Kenneth M Grundfast is licensed to practice in Massachusetts (license number 160725) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1336101054.

Contact Information

Kenneth M Grundfast, MD
820 Harrison Ave, Suite 4005,
Boston, MA 02118-2905
(617) 638-7934
Not Available



Physician's Profile

Full NameKenneth M Grundfast
GenderMale
SpecialityOtolaryngology
Experience55 Years
Location820 Harrison Ave, Boston, Massachusetts
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Kenneth M Grundfast attended and graduated from State University Of Ny Upstate Medical University in 1969
  NPI Data:
  • NPI Number: 1336101054
  • Provider Enumeration Date: 04/06/2006
  • Last Update Date: 11/03/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0446259725
  • Enrollment ID: I20110620000229

Medical Identifiers

Medical identifiers for Kenneth M Grundfast such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1336101054NPI-NPPES
110061841AMedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology MD6119 (District Of Columbia)Secondary
207Y00000XOtolaryngology 160725 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Boston Medical CenterBoston, MAHospital
Massachusetts Eye And Ear Infirmary -Boston, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Bumc Otolaryngologic Foundation Inc216340940022
Massachusetts Eye And Ear Associates, Inc4486540275337
New England Ear Nose And Throat Llc76181259317
George Washington University Medical Faculty Associates4082528898651

News Archive

Taiwan's HBV immunization program for newborns lowers chronic HBV carriers, incidence of HCC

"Hepatitis B virus infection causes infant fulminant hepatitis, and chronic HBV infection may progress to chronic liver disease and hepatocellular carcinoma. Taiwan launched a nationwide HBV immunization program for newborns in July 1984, which has successfully lowered the prevalence of chronic HBV carriers, incidence of HCC, and mortality of IFH in vaccinated birth cohorts. The mortality of CLD before and after HBV immunization has never been examined," write Chun-Ju Chiang, Ph.D., of National Taiwan University, Taipei, and colleagues.

Women's cancer outcome improved by surgical evaluation

Many women scheduled to undergo hysterectomy for pre-cancerous cell changes actually need a more comprehensive surgery, something they should discuss with a gynecologic oncologist, say researchers at the University of Alabama at Birmingham (UAB).

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

FDA (or the Agency) approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. Beginning many years before Makena was approved, a version of the active ingredient of Makena has been available to patients whose physicians requested the drug from a pharmacist who compounded the drug.

New research project aims at improving companion diagnostics and therapy of tumor diseases

An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. The idea is to combine the use of nanomedicines and short half-life radionuclides for imaging purposes in the living organism.

Health law could require some American Indians to buy insurance or pay penalties

The Associated Press reports that the overhaul's definition of "American Indian" only includes those tribes that are recognized by the federal government, though more than 100 tribes are recognized by state governments but not that U.S. Bureau of Indian Affairs. Other outlets report on insurance rates under the ACA, doctor-owned hospitals and the much lamented "doc fix" in Congress.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Kenneth M Grundfast allows following entities to bill medicare on his behalf.
Entity NameMassachusetts Eye And Ear Associates, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1932574332
PECOS PAC ID: 4486540275
Enrollment ID: O20040227000123

News Archive

Taiwan's HBV immunization program for newborns lowers chronic HBV carriers, incidence of HCC

"Hepatitis B virus infection causes infant fulminant hepatitis, and chronic HBV infection may progress to chronic liver disease and hepatocellular carcinoma. Taiwan launched a nationwide HBV immunization program for newborns in July 1984, which has successfully lowered the prevalence of chronic HBV carriers, incidence of HCC, and mortality of IFH in vaccinated birth cohorts. The mortality of CLD before and after HBV immunization has never been examined," write Chun-Ju Chiang, Ph.D., of National Taiwan University, Taipei, and colleagues.

Women's cancer outcome improved by surgical evaluation

Many women scheduled to undergo hysterectomy for pre-cancerous cell changes actually need a more comprehensive surgery, something they should discuss with a gynecologic oncologist, say researchers at the University of Alabama at Birmingham (UAB).

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

FDA (or the Agency) approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. Beginning many years before Makena was approved, a version of the active ingredient of Makena has been available to patients whose physicians requested the drug from a pharmacist who compounded the drug.

New research project aims at improving companion diagnostics and therapy of tumor diseases

An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. The idea is to combine the use of nanomedicines and short half-life radionuclides for imaging purposes in the living organism.

Health law could require some American Indians to buy insurance or pay penalties

The Associated Press reports that the overhaul's definition of "American Indian" only includes those tribes that are recognized by the federal government, though more than 100 tribes are recognized by state governments but not that U.S. Bureau of Indian Affairs. Other outlets report on insurance rates under the ACA, doctor-owned hospitals and the much lamented "doc fix" in Congress.

Read more Medical News

› Verified 6 days ago

Entity NameBumc Otolaryngologic Foundation Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942257159
PECOS PAC ID: 2163409400
Enrollment ID: O20040702001184

News Archive

Taiwan's HBV immunization program for newborns lowers chronic HBV carriers, incidence of HCC

"Hepatitis B virus infection causes infant fulminant hepatitis, and chronic HBV infection may progress to chronic liver disease and hepatocellular carcinoma. Taiwan launched a nationwide HBV immunization program for newborns in July 1984, which has successfully lowered the prevalence of chronic HBV carriers, incidence of HCC, and mortality of IFH in vaccinated birth cohorts. The mortality of CLD before and after HBV immunization has never been examined," write Chun-Ju Chiang, Ph.D., of National Taiwan University, Taipei, and colleagues.

Women's cancer outcome improved by surgical evaluation

Many women scheduled to undergo hysterectomy for pre-cancerous cell changes actually need a more comprehensive surgery, something they should discuss with a gynecologic oncologist, say researchers at the University of Alabama at Birmingham (UAB).

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

FDA (or the Agency) approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. Beginning many years before Makena was approved, a version of the active ingredient of Makena has been available to patients whose physicians requested the drug from a pharmacist who compounded the drug.

New research project aims at improving companion diagnostics and therapy of tumor diseases

An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. The idea is to combine the use of nanomedicines and short half-life radionuclides for imaging purposes in the living organism.

Health law could require some American Indians to buy insurance or pay penalties

The Associated Press reports that the overhaul's definition of "American Indian" only includes those tribes that are recognized by the federal government, though more than 100 tribes are recognized by state governments but not that U.S. Bureau of Indian Affairs. Other outlets report on insurance rates under the ACA, doctor-owned hospitals and the much lamented "doc fix" in Congress.

Read more Medical News

› Verified 6 days ago

Entity NameNew England Ear Nose And Throat Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013279108
PECOS PAC ID: 7618125931
Enrollment ID: O20120912000005

News Archive

Taiwan's HBV immunization program for newborns lowers chronic HBV carriers, incidence of HCC

"Hepatitis B virus infection causes infant fulminant hepatitis, and chronic HBV infection may progress to chronic liver disease and hepatocellular carcinoma. Taiwan launched a nationwide HBV immunization program for newborns in July 1984, which has successfully lowered the prevalence of chronic HBV carriers, incidence of HCC, and mortality of IFH in vaccinated birth cohorts. The mortality of CLD before and after HBV immunization has never been examined," write Chun-Ju Chiang, Ph.D., of National Taiwan University, Taipei, and colleagues.

Women's cancer outcome improved by surgical evaluation

Many women scheduled to undergo hysterectomy for pre-cancerous cell changes actually need a more comprehensive surgery, something they should discuss with a gynecologic oncologist, say researchers at the University of Alabama at Birmingham (UAB).

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

FDA (or the Agency) approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. Beginning many years before Makena was approved, a version of the active ingredient of Makena has been available to patients whose physicians requested the drug from a pharmacist who compounded the drug.

New research project aims at improving companion diagnostics and therapy of tumor diseases

An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. The idea is to combine the use of nanomedicines and short half-life radionuclides for imaging purposes in the living organism.

Health law could require some American Indians to buy insurance or pay penalties

The Associated Press reports that the overhaul's definition of "American Indian" only includes those tribes that are recognized by the federal government, though more than 100 tribes are recognized by state governments but not that U.S. Bureau of Indian Affairs. Other outlets report on insurance rates under the ACA, doctor-owned hospitals and the much lamented "doc fix" in Congress.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kenneth M Grundfast is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kenneth M Grundfast, MD
820 Harrison Ave, Suite 4005,
Boston, MA 02118-2905

Ph: () -
Kenneth M Grundfast, MD
820 Harrison Ave, Suite 4005,
Boston, MA 02118-2905

Ph: (617) 638-7934

News Archive

Taiwan's HBV immunization program for newborns lowers chronic HBV carriers, incidence of HCC

"Hepatitis B virus infection causes infant fulminant hepatitis, and chronic HBV infection may progress to chronic liver disease and hepatocellular carcinoma. Taiwan launched a nationwide HBV immunization program for newborns in July 1984, which has successfully lowered the prevalence of chronic HBV carriers, incidence of HCC, and mortality of IFH in vaccinated birth cohorts. The mortality of CLD before and after HBV immunization has never been examined," write Chun-Ju Chiang, Ph.D., of National Taiwan University, Taipei, and colleagues.

Women's cancer outcome improved by surgical evaluation

Many women scheduled to undergo hysterectomy for pre-cancerous cell changes actually need a more comprehensive surgery, something they should discuss with a gynecologic oncologist, say researchers at the University of Alabama at Birmingham (UAB).

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

FDA (or the Agency) approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. Beginning many years before Makena was approved, a version of the active ingredient of Makena has been available to patients whose physicians requested the drug from a pharmacist who compounded the drug.

New research project aims at improving companion diagnostics and therapy of tumor diseases

An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. The idea is to combine the use of nanomedicines and short half-life radionuclides for imaging purposes in the living organism.

Health law could require some American Indians to buy insurance or pay penalties

The Associated Press reports that the overhaul's definition of "American Indian" only includes those tribes that are recognized by the federal government, though more than 100 tribes are recognized by state governments but not that U.S. Bureau of Indian Affairs. Other outlets report on insurance rates under the ACA, doctor-owned hospitals and the much lamented "doc fix" in Congress.

Read more News

› Verified 6 days ago


Otolaryngology Doctors in Boston, MA

Dr. Steven D. Rauch, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 243 Charles St, Boston, MA 02114
Phone: 617-523-7900    
Elliott D. Kozin, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 243 Charles St, Boston, MA 02114
Phone: 617-573-6545    
Katherine Nicole Vandenberg, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 830 Harrison Ave Ste 1400, Boston, MA 02118
Phone: 617-638-8124    
Yoon Sun Chun, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 75 Francis St, Brigham And Women's Hospital Dept Of Plastic Surgery, Boston, MA 02115
Phone: 617-732-8181    Fax: 617-983-4534
Jaimie Derosa, M.D.
Otolaryngology
Medicare: Not Enrolled in Medicare
Practice Location: 91 Newbury St, Suite 300, Boston, MA 02116
Phone: 617-262-8000    Fax: 617-262-8002
Dr. Usama M Aboelkheir, MD
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 736 Cambridge St, Smc8, Boston, MA 02135
Phone: 617-789-5004    Fax: 617-779-6481
Phillip C Song, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 243 Charles St, Boston, MA 02114
Phone: 617-573-3557    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.